Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | F2 | P00734 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8527627 | 1.00 | MAPT (0.40) | MAPTGAAPOLBHPGDKMT2A | |
| SCHEMBL8029026 | 0.96 | PKM (0.38) | MAPTGAAPOLBHPGDKMT2A | |
| SCHEMBL8049722 | 0.96 | PKM (0.38) | MAPTGAAPOLBHPGDKMT2A | |
| SCHEMBL8030907 | 0.96 | MAPT (0.42) | MAPTGAAPOLBHPGDKMT2A | |
| SCHEMBL9763935 | 0.95 | MAPT (0.41) | MAPTGAAPOLBHPGDKMT2A | |
| SCHEMBL7521465 | 0.93 | HTT (0.36) | MAPTGAAPOLBKMT2AHTT | |
| SCHEMBL9763551 | 0.93 | PKM (0.40) | MAPTGAAPOLBHPGDKMT2A | |
| SCHEMBL8078011 | 0.93 | HTT (0.36) | MAPTGAAPOLBKMT2AHTT | |
| SCHEMBL8078007 | 0.93 | HTT (0.36) | MAPTGAAPOLBKMT2AHTT | |
| SCHEMBL6748513 | 0.93 | HTT (0.36) | MAPTGAAPOLBKMT2AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10457869-B2 | Liquid crystal composition and liquid crystal display device | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2019-10-29 | — | — | US | disclosed |
| US-20180037818-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2018-02-08 | — | — | US | disclosed |
| US-20170355906-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | DIC CORPORATION (JP) | 2017-12-14 | — | — | US | disclosed |
| US-20170355906-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | DIC CORPORATION (JP) | 2017-12-14 | — | — | US | disclosed |
| US-9828549-B2 | Liquid crystal composition, liquid crystal display device, and liquid crystal display | DIC CORPORATION (JP) | 2017-11-28 | — | — | US | disclosed |
| US-9828549-B2 | Liquid crystal composition, liquid crystal display device, and liquid crystal display | DIC CORPORATION (JP) | 2017-11-28 | — | — | US | disclosed |
| US-9822304-B2 | Liquid crystal composition and liquid crystal display element containing the same | DIC CORPORATION (JP) | 2017-11-21 | — | — | US | disclosed |
| US-9822304-B2 | Liquid crystal composition and liquid crystal display element containing the same | DIC CORPORATION (JP) | 2017-11-21 | — | — | US | disclosed |
| US-20170210986-A1 | LIQUID CRYSTAL DISPLAY ELEMENT | DIC CORPORATION (JP) | 2017-07-27 | — | — | US | disclosed |
| US-20170210986-A1 | LIQUID CRYSTAL DISPLAY ELEMENT | DIC CORPORATION (JP) | 2017-07-27 | — | — | US | disclosed |
| US-8366962-B2 | Polymerizable liquid crystal compounds having oxiranyl group, polymerizable liquid crystal compositions and polymers | JNC CORPORATION (JP) | 2013-02-05 | — | — | US | disclosed |
| US-8366962-B2 | Polymerizable liquid crystal compounds having oxiranyl group, polymerizable liquid crystal compositions and polymers | JNC CORPORATION (JP) | 2013-02-05 | — | — | US | disclosed |
| US-20110147656-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUNDS HAVING OXIRANYL GROUP, POLYMERIZABLE LIQUID CRYSTAL COMPOSITIONS AND POLYMERS | CHISSO CORPORATION (JP) | 2011-06-23 | — | — | US | disclosed |
| US-20110147657-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION AND ANISOTROPIC POLYMER | CHISSO CORPORATION (JP) | 2011-06-23 | — | — | US | disclosed |
| US-20110086185-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND AND ITS POLYMER | CHISSO CORPORATION (JP) | 2011-04-14 | — | — | US | disclosed |
| EP-0733692-B1 | Liquid crystalline compound, liquid crystal composition containing the same, and display device | CHISSO CORP (JP) | 2000-06-14 | — | — | EP | disclosed |
| EP-0733610-B1 | Liquid crystalline compound, liquid crystal composition containing the same and liquid crystal display device | CHISSO CORP (JP) | 1998-10-28 | — | — | EP | disclosed |
| CN-1140194-A | Liquid crystalline compound having branched alkyl group at its side chain and liquid crystal composition containing the same | CHISSO CORP (JP) | 1997-01-15 | — | — | CN | disclosed |
| EP-0733692-A1 | Liquid crystalline compound, liquid crystal composition containing the same, and display device | Chisso Corporation (JP) | 1996-09-25 | — | — | EP | disclosed |
| EP-0733610-A1 | Liquid crystalline compound, liquid crystal composition containing the same and liquid crystal display device | Chisso Corporation (JP) | 1996-09-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086185-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND AND ITS POLYMER | CCNT1, POF1B, CCND3 | MAPT 2658/4885GAA 4841/4885POLB 1480/4885 |
| US-20110147657-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION AND ANISOTROPIC POLYMER | SSB, LEF1, UACA | MAPT 12/4885GAA 4666/4885POLB 800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.